MiR-214, miR-4465, and miR-137 targeted EZH2 respectively in hepatocellular carcinoma cell line SK-HEP-1, in non-small cell lung cancer cell lines A549 and H2170, and in melanoma cell lines Ma-Mel-79b and -86b [72,73,74]. This evidence concerns the gene EZH2 and hepatocellular carcinoma.